ALICE DAVIS: Open Payments
NPI 1598741621 · KIRKSVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 7 payments from 7 companies in 2025. Trend: 2023 $191 · 2024 $270 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $108 |
| PFIZER INC. | 1 | $104 |
| Teva Pharmaceuticals USA, Inc. | 1 | $102 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: Wegovy, PENBRAYA, AUSTEDO XR, REXULTI, BREZTRI, LEQVIO.
Industry payments across MO — which companies pay providers there.
